Echinacea pallida
Natural health product licensed in Canada
- Other names
- Pale echinacea, Pale purple coneflower, Pale-flowered Echinacea
- Licence holder
- Dr. Ma's Laboratories Inc.
- NPN or DIN-HM
- 80090845
- Status
- Active licence
- Licence date
- 21 February 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Echinacea pallida Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 2,000 milligramme | 500 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Hypromellose, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 10 years ; maximum: 14 years | 2 Capsule | 1 Tous les jours |
| Adultes et adolescents | minimum: 15 years | 3 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine to help relieve cold symptoms. Supportive therapy in the treatment of upper respiratory tract infections (e.g., common colds). Helps to relieve the symptoms and shorten the duration of upper respiratory tract infections.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/ physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection or an auto-immune disorder. Consult a health care practitioner /health care provider/health care professional/doctor/ physician prior to use if you are taking medications to suppress the immune system (immunosuppressive medications).
Source
Official Health Canada record, licence 80090845
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.